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Muscle-specific Drp1 overexpression impairs skeletal
muscle growth via translational attenuation
T Touvier1, C De Palma2, E Rigamonti3, A Scagliola3,4, E Incerti3,4, L Mazelin5, J-L Thomas5, M D'Antonio6, L Politi7, L Schaeffer5,
E Clementi*,1,2 and S Brunelli*,3,4
Mitochondrial fission and fusion are essential processes in the maintenance of the skeletal muscle function. The contribution of
these processes to muscle development has not been properly investigated in vivo because of the early lethality of the models
generated so far. To define the role of mitochondrial fission in muscle development and repair, we have generated a transgenic
mouse line that overexpresses the fission-inducing protein Drp1 specifically in skeletal muscle. These mice displayed a drastic
impairment in postnatal muscle growth, with reorganisation of the mitochondrial network and reduction of mtDNA quantity,
without the deficiency of mitochondrial bioenergetics. Importantly we found that Drp1 overexpression activates the stress-induced
PKR/eIF2α/Fgf21 pathway thus leading to an attenuated protein synthesis and downregulation of the growth hormone pathway.
These results reveal for the first time how mitochondrial network dynamics influence muscle growth and shed light on aspects of
muscle physiology relevant in human muscle pathologies.
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Skeletal muscle growth and mitochondrial metabolism are
intimately linked. In myogenic precursor cells, mitochondrial
mass, mtDNA copy number and mitochondrial respiration
increase after the onset of myogenic differentiation;1,2
furthermore, postnatal development of fast-twitch muscle is
accompanied by an increase in mtDNA copy number3 and
muscle regeneration is impaired when mitochondrial protein
synthesis is inhibited with chloramphenicol.2,4 These observa-
tions suggest that a change in the mitochondrial metabolism is
necessary for proper muscle development. During myogen-
esis and postnatal development, the shape of mitochondria is
also remodelled:3,5,6 in an elegant mouse model with
fluorescent mitochondria it was shown that in young mice
mitochondria of the extensor digitorum longus (EDL) muscle
are shaped as elongated tubules oriented along the long axis
of the muscle fibre, whereas in adult mice mitochondria are
punctuated and organised into doublets.1
Mitochondrial network morphology is controlled by the
balance between fusion and fission. In mammals, three large
GTPases are involved in mitochondrial fusion: mitofusins 1
and 2 (Mfn1 and Mfn2) participate in the early steps of
mitochondrial outer-membrane fusion, whereas the optic
atrophy 1 protein (Opa1) is essential for inner-membrane
fusion.7 Mitochondrial fission is mediated by the evolutionarily
conserved dynamin-related protein 1 (Drp1).8 In humans,
mutations in Mfn2 and Opa1 cause two neurodegenerative
diseases – Charcot–Marie–Tooth type 2 A and dominant optic
atrophy, respectively – and a mutation in Drp1 has been linked
to neonatal lethality with multisystem failure.9–11 Moreover,
Drp1 expression was reported to increase in a model of
cachexia12 and to contribute to muscle insulin resistance in
obese and type 2 diabetic mice.13,14
The importance of mitochondrial dynamics in muscle
physiology has become increasingly clear. In skeletal muscle,
mitochondria undergo fusion to share matrix content in order
to support excitation–contraction coupling.15 The mitochon-
drial network is remodelled in atrophic conditions, and
denervation and expression of fission machinery in adult
myofibres is sufficient to cause muscle wasting.16 Moreover,
mice lacking Mfn1 and 2 in fast-twitch muscles exhibit drastic
growth defects and muscle atrophy before dying at 6–8 weeks
of age.3 Animal models in which mitochondrial fission proteins
are manipulated during skeletal muscle development are not
yet available, but in vitro data demonstrate that regulation of
Drp1 is critical for myogenesis: myoblasts differentiation
requires nitric oxide-dependent inhibition of Drp16 and
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pharmacological inhibition of Drp1 activity impairs myogenic
differentiation.17
To explore in vivo the role of Drp1 and mitochondrial shape
in the developing muscle, we generated a transgenic mouse
line specifically overexpressing Drp1 in skeletal muscle during
myogenesis. These mice display strong impairments in
mitochondrial network shape and in muscle growth. We show
that the mechanism responsible for the growth defect involves
inhibition of protein synthesis and activation of the Atf4
pathway.
Results
Mice overexpressing Drp1 in muscle have reduced
muscle mass and compromised exercise performance.
We generated a transgenic mouse that overexpresses Drp1
after Cre recombinase-mediated excision of floxed nuclear
DsRed sequence (Figure 1a). Drp mice were crossed with
MyoDiCre transgenic mice, expressing Cre in myogenic
cells.18 In double transgenic mice (Drp/MC), Drp1 protein
was indeed overexpressed in muscles but not in the liver
(Figure 1b). Analysis in EDL and soleus, respectively, a
glycolytic and an oxidative muscle, showed that Drp1
expression increased in the mitochondrial protein fraction
(Figure 1b). No significant changes were found in the levels of
expression of the fusion proteins Mfn1, Mfn2 and Opa1
(Figure 1c). Drp/MC mice developed normally but displayed a
growth defect starting 1 week after birth. At P100 body weight
of transgenic animals was reduced by 20% compared with
the wild-type (WT) mice (Figure 1d and Table 1). This defect
was not because of a reduced food intake (Supplementary
Table S1). Accordingly, levels of blood metabolites (triglycer-
ides and glucose) and hormones (insulin, glucagon and
leptin) did not differ significantly between Drp/MC and WT
mice (Supplementary Table S1). Computerised tomography
analyses in Drp/MC mice showed a significant reduction of
total body volume and specific decreases of muscle and
skeleton volumes (Supplementary Table S2). The length of
the tibia bone was similar in WT and transgenic animals,
indicating that Drp1 overexpression does not alter the whole-
body growth: diminution of skeleton volume may be a
consequence of decreased muscle and weight loading.19
Reduction of muscle mass was mainly because of a
significant decrease in the weight of glycolytic muscles, such
as tibialis anterior (TA), gastrocnemius and quadriceps
(−50% vs WT), whereas the weights of oxidative muscles
(soleus and diaphragm) were weakly affected (Table 1 and
Figure 1e). This muscle phenotype strongly impacts on the
locomotor performance of transgenic mice both in short-term
high-intensity exercise and in long-term low-intensity running
test (Figure 1f).
Muscle-specific overexpression of Drp1 impairs post-
natal skeletal muscle growth. We investigated whether the
phenotype observed in adult animals was due to defect in
Figure 1 Mice overexpressing Drp1 (Drp/MC) in muscle have a severe reduction of muscle mass. (a) Transgene construct. (b) Left: Drp1 and Myc proteins were analysed by
western blot in EDL and soleus muscles and liver of WT and transgenic animals, right: Drp1 expression in mitochondrial extract was analysed by western blot. Cyclophilin D
(CypD) is used as a loading control. (c) Mitofusin 1 (Mfn1), Mitofusin 2 (Mfn2) and Opa1 expression was analysed by western blot. Quantification is given in the right chart (n= 4
animals per genotype). (d) Growth curve of WTand Drp/MC animals (n= 5 animals per group). (e) Pictures of WTand Drp/MC Tibialis anterior (TA), EDL and soleus muscles.
(f) Speed and distance performed by P200 WTand transgenic mice on treadmill tests evaluating power and resistance (n= 7 animals per genotype). Error bars represent S.E.M.
***Po0.001 versus wt
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muscle development. At birth, Drp/MC newborns were
indistinguishable from their control littermates, with normal
gross morphology and myofibres cross-sectional area (CSA)
(Figure 2a). One week after birth (P7), the mean CSA of Drp/
MC myofibres was slightly reduced but not statistically
different from that of WT controls (n= 3 per genotype,
P= 0.10, Figure 2b). Myofibres CSA became significantly
less in transgenic mice at P25 and P100 (−40 to –50%,
Figures 2c and d). In adult transgenic mice, haematoxylin and
eosin (H&E) staining showed a normal overall muscle
morphology without inflammatory infiltrate and/or centrally
nucleated fibres (Figure 2d). Likewise, we did not find
alterations in the localisation and morphology of the
neuromuscular junctions as indicated by the staining for the
acetylcholine receptor and Sv2 (Supplementary Figure S1).
Immunofluorescence (IF) for myosin heavy chains (MHC) 2A
and 2B in the TA indicated that the myofibre typology of Drp/
MC was unaffected (Supplementary Figure S2). The total
number of TA myofibres, the mean number of myonuclei and
the number of Pax7 positive satellite cells per fibre was
similar in transgenic and WT mice (Figures 2e and f)
suggesting that embryonic/fetal myogenesis occurs normally
and that fusion of satellite cells to the pre-existing fibres
during perinatal myogenesis is not impaired. Moreover
muscle regeneration after cardiotoxin damage, a process
that involves proliferation, fusion and differentiation of satellite
cells, occurred in transgenic animals with the same time
course as in WT counterparts (Supplementary Figure S3)
thus confirming that satellite cells function is not impaired in
Drp/MC mice.
In order to investigate the molecular pathways responsible
for the reduced muscle growth, we analysed the activation
of the ubiquitin–proteasome and the autophagy-lysosome
systems. The expression of the ubiquitin ligases Atrogin-1/
MAFbx, MuRF1 and Mul1 did not differ in developing
and mature Drp/MC muscles, (Supplementary Figure S4). In
muscles from Drp/MC and WT animals the levels of lipidated
microtubule-associated protein-1 light chain 3 (LC3-II) and
p62, two markers of autophagy (Supplementary Figure S4),
were similar, as well as the phosphorylation levels of AMPK,
the cell sensor of energy balance (Supplementary Figure S4).
Taken together, these data suggest that embryonic, fetal
and perinatal myogenesis occur properly in transgenic
animals and that Drp1 overexpression impairs the increase
in myofibres size during the perinatal/postnatal period without
changes in satellite cells function or activation of catabolic
pathways.
Postnatal mitochondrial network remodelling is impaired
in Drp/MC muscle. We next analysed whether Drp1 over-
expression affects the activity and distribution of mitochondria
by staining muscle TA sections for succinate dehydrogenase
(SDH) activity. At P1 no differences were observed between
Drp/MC and WTanimals (Figure 3a). In Drp/MC P7 muscles,
the intensity of SDH staining, a proxy for oxidative capacity,
was slightly reduced (Figure 3a) and, at P25, it was found in
punctuated units in most fibres and some were completely
devoid of oxidative capacity in their core (Figure 3a). In adult
Drp/MC muscles (P100), the oxidative capacity of mitochon-
dria was found restricted to the fibre periphery (Figure 3b).
Similar results were observed with cytochrome oxidase
(COX) staining (Supplementary Figure S5). To visualise
specifically the structure and not only the activity of the
mitochondria, we crossed Drp/MC transgenic mice with
PhAM transgenic mice, a line with photo-activatable
mitochondria.1 In control PhAM TA, we observed the typical
striated distribution of inter-myofibrillar and sub-sarcolemmal
mitochondria. By contrast, Drp/MC/PhAM muscles displayed
a severe remodelling of the mitochondrial network, lacking
most of the internal inter-myofibrillar mitochondria (Figure 3c
and Supplementary Movies 1 and 2). Electron microscopy
analysis of TA myofibres of Drp/MC mice revealed an overtly
normal myofibre ultrastructure, still the mitochondrial network
was clearly altered, with virtual absence of the inner pool of
inter-myofibrillar mitochondria. In addition, while many mito-
chondria showed a normal structure, some appeared
swollen, with no or fewer than normal cristae (Figure 3e).
Accordingly we found that GTP-binding activity of Opa1 that
resides in the inner mitochondrial membrane was largely
decreased in Drp/MC muscles (Figure 3f).
This mitochondrial network alteration was not due to
changes in mitochondrial number or turnover: the mitochon-
drial mass assessed by the protein levels of Tim23 and
Table 1 Tissue measurements in P100 wild-type and Drp/MC mice
Females Males
WT Drp/MC WT Drp/MC
Body weight (g) 25± 2 21±0** 30±1 25±2**
Tibialis anterior (mg) 47± 3 22±1*** 54±2 31±4***
EDL (mg) 10± 0 5±1*** 12±1 6±1***
Soleus (mg) 10± 0 7±1* 9±0 9±1
Gastrocnemius (mg) 181± 8 103±6*** 187±7 117±14***
Quadriceps (mg) 179± 13 93±4*** 197±13 122±18***
Diaphragm (mg) 86± 11 73±7 87±3 80±4
Heart (mg) 137± 8 117±3 147±8 151±11
Perigonadal AT (mg) 603± 130 418±44 658±102 460±80
Liver (mg) 1409± 156 1200±61 1549±102 1566±100
Kidney (mg) 399± 32 361±12 503±28 505±33
Spleen (mg) 131± 16 116±5 103±7 113±18
Data are given ± S.E.M. N⩾ 4 mice per group. T- test vs WT, *Po0.05 **Po0.01 ***Po0.001
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Cyclophilin D, did not differ between WT and transgenic
animals (Figure 3d). Accordingly, protein levels of PGC1α, a
master regulator of mitochondrial biogenesis were similar
(Supplementary Figure S6A). In addition, the levels of
membrane-anchored LC3 (LC3-II) was comparable in WT
and Drp/MC muscles and no co-localisation between phago-
somes and mitochondria was observed (Supplementary
Figure S6B and S6C), indicating that mitophagy was not
triggered.
Overall these data suggest that Drp1 overexpression affects
the mitochondrial structure and impairs the normal
remodelling of the mitochondrial network in growing muscle
by redistributing mitochondria close to the sarcolemma and/or
myonuclei.
Mitochondrial DNA content is reduced and a mitochon-
drial unfolded protein response (mtUPR) is activated in
Drp/MC muscles. To investigate specifically the mitochon-
drial functionality in Drp/MC muscles, we measured their
membrane potential in myofibres from WT and Drp/MC
gastrocnemius by using the fluorochrome tetramethyl rhoda-
mine methyl ester (TMRM). In WT fibres, we observed the
Figure 2 Muscle-specific Drp1 overexpression impairs postnatal muscle growth. (a, b, c) Representative images of immunofluorescence on TA sections from P1 (a), P7 (b) and
P25 (c) mice by using a laminin-specific antibody. Original magnification x20, scale bar 50um. Frequency histogram showing the distribution of myofibre CSA in WTand Drp/MC TA
muscles from P1 (a), P7 (b) and P25 (c) mice. Per condition, at least 500 fibres were counted. Mean myofibre CSA in WTand Drp/MC from P1 (a), P7 (b) and P25 (c) mice (n≥ 3
animals per genotype). (d) Representative sections of WTand Drp/MC TA muscles from P100 mice stained with H&E. Representative images of immunofluorescence on TA sections
by using a laminin-specific antibody. Frequency histogram showing the distribution of myofibre CSA in WTand Drp/MC TA muscles from P100 mice. Mean myofibre CSA in WTand
Drp/MC (n= 3 animals per genotype). (e) Mean number of myofibres muscle (n= 3 animals per genotype). (f) Mean number of myonuclei and Pax7 positive cells in WTand Drp/MC
single fibres (n= 4 preparations per genotype). Original magnification x20, scale bar: 50 μm. Error bars represent S.E.M. **Po0.01; *Po0.05 versus WT
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expected pattern with functional mitochondria arranged in a
stereotypic manner in relation with the sarcomeric unit. In
Drp/MC fibres, functional mitochondria were preferentially
localised close to myonuclei (Supplementary Figure S7).
We tested whether mitochondria of Drp/MC muscle display a
latent dysfunction, that is, masked by the ATP synthase
consuming ATP to maintain the mitochondrial membrane
potential.20 Administration of the ATP synthase inhibitor
oligomycin fibres increased the mitochondrial membrane
potential in both WT and Drp/MC muscles suggesting that
Figure 3 Muscle-specific Drp1 overexpression induces a drastic remodelling of mitochondrial network. (a) SDH staining of transversal sections from WTand Drp/MC from
P1, P7, P25 TA muscles. Original magnification × 20, scale bar: 50 μm. (b) SDH staining of transversal and longitudinal sections from WTand Drp/MC P100 TA muscle. Low
magnification, × 4; high magnification, × 40. (c) Representative confocal images of mitochondrial network in PhAM and Drp/MC/PhAM TA myofibres from P100 animals.
Transversal and longitudinal optical sections are also shown. Original magnification x40, scale bar: 10 μm. (d) Western blot analysis of Tim23 and Cyclophilin D (CypD) protein
expression levels in mitochondrial protein lysates from quadriceps of adult WT and Drp/MC mice. Gapdh was used as internal control. (e) Electron microscopy analysis of TA
muscles from P100 Drp/MC and WT mice. Arrows point to swollen mithocondria, with none or fewer than normal cristae. (f) Western blot analysis of Opa1 GTPase activity after
pull-down experiments using GTP-conjugated beads
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Drp/MC mitochondria are healthy (Figure 4a). Consistently,
the rates of oxygen consumption, measured with substrates
targeting complex I, II and IV in saponin-skinned fibres by
oxygraphy, were similar in WT and Drp/MC mice (Figure 4b).
Similarly, we found no differences in ATP levels produced
through oxidative phosphorylation in isolated TA mitochondria
(Figure 4c). These data indicate that Drp1 overexpression
does not alter mitochondrial bioenergetics.
Figure 4 Mitochondrial bioenergetics remained unchanged but mtDNA content is reduced and a mtUPR response is activated in Drp/MC muscle. (a) Fibres were loaded with
the mitochondrial potentiometric dye TMRM (25 nM) and the fluorescence was recorded for 40 min. The arrows indicate the time of addition of oligomycin (Oligo; 5 μM) and FCCP
(4 μM). (b) Mitochondrial respiration in permeabilised TA myofibres was measured by using high-sensitivity respirometer (n= 8 animals per genotype); complex I (CI), complex II
(CII) and complex IV (CIV). (c) Isolated mitochondria from TA muscle were incubated with luciferin-luciferase and the ATP generated through oxidative phosphorylation was
measured (n= 9 animals per genotype). (d) Mitochondrial DNA (mtDNA) content in TA muscle from P7 and P100 animals (n= 8 per genotype). (e) RT-qPCR analysis of mtDNA
and nuclear DNA encoded respiratory chain subunits in P100 quadriceps muscle. (f) RT-qPCR analysis of Chop mRNA levels in quadriceps from P7, P25 and P100 WTand Drp/
MC mice (n= 8 per genotype). (g) Western blot analysis of Hsp60 and ClpP protein expression levels in quadriceps from adult WTand Drp/MC mice (n= 8 per genotype). Actin
was used as control. (h) RT-qPCR analysis of Atpif1 mRNA levels in quadriceps from P100 WTand Drp/MC mice (n= 8 per genotype). (i) Western blot analysis of ATPIF1 protein
expression levels in quadriceps from adult WTand Drp/MC mice (n= 8 per genotype). Tim23 and Complex II (CII) were used as control. Error bars represent S.E.M. *Po0.05,
**Po0.01, ***Po0.001 versus WT; ##Po0.01, ###Po0.001 versus P7 mice
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We then assessed whether Drp1 overexpression affects the
increase in mtDNA that accompanies postnatal muscle
development.3 As expected, we observed an increase in the
mtDNA copy number between P7 and P100 mice; this
increase, however, was 40% lower in Drp/MC mice with
respect to WT mice (Figure 4d). Consistently, we observed a
decrease in mRNA levels of the subunits of the electron
transport respiratory chain encoded bymtDNA. No differences
were found for subunits encoded by nuclear DNA (Figure 4e).
Since low-mtDNA amount induces a mitochondrial stress
and a subsequent mitochondrial mtUPR upregulation,21 we
measured the expression of mtUPR markers. mRNA levels of
the C/EBP homologous protein (Chop), a master gene
involved in mtUPR response22 increased significantly in Drp/
MC quadriceps during the postnatal period (Figure 4f).
Mitochondria-specific chaperonin 60 (Hsp60) and the pro-
tease ClpP, both hallmarks of the mtUPR were upregulated in
quadriceps (Figure 4g), but not in liver and diaphragm
(Supplementary Figure S8), of Drp/MC mice. Downregulation
of the ATP synthase inhibitor ATPIF1 has been shown to
ameliorate mitochondrial respiratory chain dysfunction;23
mRNA and protein levels of ATPIF1 were significantly reduced
in Drp/MC quadriceps (Figures 4h and i). Overall these data
suggest that Drp1 overexpression reduces mtDNA quantity
and activates a specific protective response involving
mitochondrial chaperones and ATPIF1, which successfully
preserves the mitochondrial function.
We verified whether mtUPR was associated to a classical
UPR induced by ER stress. We found no alterations in mRNA
levels of the ER-resident heat shock protein 70 (HSP70) family
members BIP/GRP78 and GRP94, nor splicing of X box
binding protein 1 (XBP-1) mRNA in Drp/MC muscles
(Supplementary Figure S9). Thus Drp1 overexpression
induced specific mitochondrial stress and mtUPR.
Muscle-specific Drp1 overexpression inhibits protein
synthesis and induces Atf4 pathway. In order to investi-
gate the mechanisms responsible for the reduced postnatal
muscle growth, we monitored protein synthesis by analysing
polysome profile in control and Drp/MC P40 muscles by using
sucrose gradient centrifugation (Figure 5a). This allowed to
separate polysomes from monosomes, ribosomal subunits
and messenger ribonucleoprotein particles (mRNPs) and
enabled discrimination between efficiently translated (asso-
ciated with heavy polysomes) and poorly translated (asso-
ciated with light polysomes) mRNAs. In Drp/MC muscles, we
observed a huge reduction of medium and heavy polysomes
(fractions 8–12), concomitant with elevated levels of free
ribosomes and light polysomes, indicating that translation
initiation is severely altered.
We also verified whether the AKT/GSK3β/mTOR pathway, a
crucial regulator a protein synthesis, wasmodulated. Although
levels of both total and phosphorylated forms of 4EBP1 andS6
were increased in Drp/MC muscles, possibly because of the
alteration of protein synthesis observed above, the phosphor-
ylation levels of AKTand GSK3β were similar in WTand Drp/
MC muscles. (Supplementary Figure S10), suggesting that
the mTOR pathway is not involved in the translation impair-
ment observed.
Eukaryotic initiation factor 2 alpha (eIF2a) is another crucial
regulator of protein translation. Its phosphorylation at Ser-51
reduces the global translation initiation while enhancing the
translation of selected mRNAs, such as those activating
transcription factor (Atf4), a master gene of the integrated
stress response.24 Mitochondrial stress was recently shown to
activate the eIF2α stress-response pathway in a double-
stranded RNA-activated protein kinase (PKR) dependent
way.25 We found that phosphorylation levels of eIF2α were
highly increased in transgenic muscles (Figure 5b), as well as
expression of the phosphorylated form of PKR (Figure 5c)
suggesting that Drp1-mediated mitochondrial stress activates
PKR, which in turn phosphorylates eIF2α. Consistently, we
observed in transgenic muscles a substantial shift of Atf4
and Chop transcripts to the large polysome fractions26
(Figure 5d and Supplementary Figure S11A). Conversely
there is a trend of MHC transcripts being decreased
associated with larger polysomes, in agreement with the
reduced content of myosin proteins (Supplementary
Figures S11B-C). As a control, we measured the levels of
36B4 mRNA and found that this transcript was insensitive to
the integrated stress response induced by Drp1 overexpres-
sion (Supplementary Figure S11D).
Atf4 activates the transcription of many target genes in
muscle that may interferewithmuscle growth.27 Indeed growth
arrest and DNA-damage-inducible protein alpha (Gadd45a)
and fibroblast growth factor 21 (Fgf21) were upregulated
in transgenic muscles (Figure 5e). In mouse models of
mitochondrial diseases as well as in human patients, skeletal
muscle is known to secrete high amount of Fgf21.28 In adult
Drp/MC mice, serum Fgf21 concentration was 14-fold higher
compared with control mice (WT 148±25 vs Drp/MC
2084±269 pg/ml) (Figure 5f). Fgf21 and Gadd45a are both
known to repress growth hormone (GH)-dependent path-
ways:29–31 we treated adult WT and Drp/MC mice with hGH
and measured mRNA levels of the GH target gene cytokine-
inducible inhibitor of signalling (Cish) (Figure 5g). Induction of
Cish was significantly reduced in both liver and quadriceps of
Drp/MC mice, suggesting that muscle-specific DRP1 over-
expression leads to a global reduction of GH sensitivity.
Moreover, the expression of several genes involved in GH
action was deregulated in Drp/MC quadriceps: expression of
growth hormone receptor (Ghr) and its downstream effector
Jak2 were strongly downregulated, whereas Leprotl1, a gene
that negatively regulates Ghr presence at the cell surface,32
was upregulated (Supplementary Figure S12). Altogether
these data suggest that Drp1 overexpression triggers an
adaptive stress response that prevents normal fibre growth by
attenuating general protein translation and downregulating
growth hormone anabolic pathway.
Discussion
In this study, we demonstrate that skeletal muscle-specific
overexpression of the mitochondrial fission protein Drp1
induces a reorganisation of the mitochondrial network and
impairs postnatal muscle development. Drp1 induces a
persistent activation of eIF2α/Atf4 stress-response cascade
that interferes with muscle anabolism by inducing a general
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depression of translation and by reducing growth hormone
signalling.
In mature skeletal muscle, mitochondria are tightly packed
and arranged in a stereotypic manner in relation to the
sarcomeric unit.33 This complex organisation is reached by
30 days after mouse birth and depends on mitochondrial fusion
proteins.1,3 In muscle overexpressing Drp1 we observed that
postnatal mitochondrial network remodelling does not occur
properly, and that mitochondrial distribution is drastically
redistributed towards the myonuclei. This kind of rearrangement
has been observed in cellular models defective in fission or
fusion proteins expression.5,34,35 Little, however, is known on the
role of this process apart from a possible calcium buffering
activity at the plasmalemma34 or regulation of gene transcription
via increased nuclear ROS levels.36 Drp1 overexpression also
prevents the normal increase of mtDNA quantity occurring in the
postnatal period,37 suggesting a link between mitochondrial
shape and mtDNA maintenance/replication.
Although Drp1 overexpression modulates mitochondrial
shape and DNA content, it does not affect mitochondrial
Figure 5 eIF2α/Atf4 pathway is activated in Drp/MC muscle. (a) Polysome profile in quadriceps from young (P40) WT and Drp/MC mice. Lysates were analysed by
centrifugation in a 10–50% sucrose gradient, and the profiles were measured by absorbance at 254 nm. The panel is representative of three independent experiments.
(b) Representative western blot analysis of phosphorylated and total eIF2α protein expression levels in quadriceps from P7, P25 and adult (P100) WT and Drp/MC mice.
Quantification is given in the right chart (n= 5 per genotype). (c) Western blot analysis of phosphorylated PKR protein levels after immunoprecipitation of total PKR protein from
gastrocnemius protein lysate of adult (P100) WT and Drp/MC mice (n= 3 per genotype). (d) Atf4 mRNA distribution in the fractions collected from the sucrose gradients was
determined by RT-qPCR. Percentage of Atf4 transcripts present in polysomal fractions (6–12) (n= 3 per genotype). (e) RT-qPCR analysis of representative stress-response
genes mRNA levels in quadriceps from adult WT and Drp/MC mice (n= 8 per genotype). (f) Plasma levels of Fgf21 in adult WT and Drp/MC mice (n= 11 per genotype).
(g) RT-qPCR analysis of Cish mRNA levels in quadriceps from adult WTand Drp/MC mice 4 h after GH treatment (1.5 mg/kg i.p., n= 7 per group). Error bars represent S.E.M.
*Po0.05, **Po0.01, ***Po0.001 versus WT
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polarisation, cellular respiration and ATP production. Indeed,
activation of the cellular fuel gauge AMPK and of the anabolic/
catabolic pathways controlled by energy balance (ubiquitin–
proteasome, autophagy, AKT-mTOR) is not altered in Drp/MC
muscles. Romanello et al.,16 reported that electroporation of
Drp1 and Fis1 in adult muscle promotes mitochondrial
fragmentation, mitophagy, activation of AMPK and muscle
atrophy. In our model, Drp1 overexpression is probably lower
than in their model: the resulting more moderate mitochondrial
stress could therefore be handled more easily by the muscle,
and no energy imbalance becomes unmasked, also because
of the reduced muscle growth. It is also possible that
mitochondrial alterations triggered by Drp1 overexpression
are compensated by upregulation of ATP synthase activity via
reduction of ATPIF1 levels,23 that is decreased in Drp/MC
mitochondria.
In Drp/MC muscles, we observed activation of the eIF2α
pathway, which allows the cells to adapt to various stresses by
downregulating protein translation and inducing Atf4, a
transcriptional activator of the integrated stress response.24
Interestingly, this pathway is induced when myoblasts are
pushed towards differentiation and inhibits transiently the
myogenic programme.38 In Drp1 overexpressing muscles,
eIF2α/Atf4 pathway is activated during the whole postnatal
muscle development, prior to the appearance of muscle
phenotype (around P25). Thus it is likely that activation of this
pathway is a cause rather than a consequence of altered
muscle development. Other studies have demonstrated a link
between mitochondria-shaping proteins and eIF2α phosphor-
ylation. Genetic ablation of Mfn2 (but not Mfn1) induces an
eIF2α phosphorylation as a result of ER stress and PERK
activation.39,40 In contrast, phosphorylation of eIF2α in Drp/
MC muscle is likely induced by specific mitochondrial stress,
because we observed an on-going mtUPR response and no
changes in the expression of ER stressmarkers. Moreover, we
found increased levels of phosphorylated PKR, a cytosolic
eiF2α kinase described to be activated by specific mitochon-
drial stress.25 The link between Drp1-mediated mitochondrial
alteration and PKR activation remains to be investigated.
As expected in conditions of high P-eIF2α levels, we
observed a general depression of translation and a reduced
content of MHC. In cachectic cancer patients there is an
inverse correlation between MHC expression and the phos-
phorylation levels of eIF2α,41 and tumour-derived factors such
as proteolysis inducing factor (PIF) produce a depression in
protein synthesis in murine myotubes through autophosphor-
ylation of PKR and increased phosphorylation of eIF2α.42
Increased phosphorylation of PKR/eIF2α was also observed
in muscles from diabetic mice.43 Since Drp1 expression levels
increases in cachexia and type 2 diabetes models,12,13 it is
possible that some of the events that we observed in Drp/MC
muscle are also responsible for the depression in protein
synthesis observed in these pathologies.
In Drp/MC muscles, we also observed preferential
translation of Atf4 and upregulation of its target genes,
events consistent with the phosphorylation of eIF2α.
Atf4 overexpression in adult muscle was shown to reduce
myofibres size and some of its downstream target genes may
interfere with muscle development.27 In particular Fgf21, a
sensitive marker of muscle mitochondrial diseases,28,44 was
strongly upregulated in skeletal muscles and in blood of Drp/
MCmice. Fgf21 was recently shown to inhibit growth hormone
(GH) action by increasing Leprotl1 expression.29 Accordingly,
muscles of Drp/MC mice displayed a reduced GH sensitivity,
upregulation of Leprotl1 gene expression and a downregula-
tion of genes involved in GH signalling. These alterations may
interfere with the growth-promoting action of GH during the
muscle development.45
In conclusion, our study shows that mild alteration of
balance between fusion and fission impairs specifically
muscle growth that is dependent on protein synthesis. This
is the first demonstration that increased Drp1 levels induces a
specific mitochondrial stress response and inhibits cytosolic
protein translation. It thus appears that Drp1 and its dependent
signalling are at the crossroad of pathways critical for muscle
homeostasis, such that their imbalance is observed in diverse
pathological conditions of the muscle. Manipulation of
mitochondrial dynamics and of eIF2α pathway may therefore
be useful in developing therapeutic interventions for myopa-
thies characterised by protein synthesis depression.
Materials and Methods
Generation of skeletal muscle-specific Drp1 transgenic mice. To
generate the Drp1 transgenic mice Drp1 ORF was inserted into the piGAP vector.46
Drp transgenic mice were crossed with heterozygous MyoDiCre knockin mice.18
Details on the cloning and animal experimentation are provided in Supplemental
Experimental Procedures. All experiments conformed to Italian law and were
performed under internal regulations for animal care and handling (San Raffaele
Institute IACUC 355 and 489).
Western blot analysis and Immunoprecipitation. Muscle and liver
tissues were homogenised in lysis buffer containing 20 mM HEPES pH 7.4, 150 mM
NaCl, 2% sodium dodecyl sulphate (SDS), protease and phosphatase inhibitor
mixture (Roche, Basel, Switzerland) and centrifuged at 1000 × g for 10 min at 4 °C
to discard cellular debris. Western blot analyses were performed as described.6 For
PKR expression studies, gastrocnemius muscle from adult WT and transgenic mice
were homogeneised in lysis buffer containing 20 mM HEPES pH 7.4, 150 mM NaCl,
1 mM EDTA, 10% glycerol, 1% Triton X100, protease and phosphatase inhibitor
mixture (Roche). A total of 1.5 mg of lysate was incubated overnight at 4 °C with
4 μg of antibody against total PKR. The complexes were pelleted with protein
A–Sepharose (Invitrogen, Carlsbad, CA, USA), and then separated by SDS-PAGE
with an antibody against PKR. Details on the antibodies are provided in
Supplementary Table S3.
Histology and immunofluorescence. Serial muscle sections were
stained with H&E (Sigma-Aldrich, St. Louis, MO, USA) or succinic dehydrogenase
staining (Bio-Optica, Milano, Italy). IF staining was performed as
in Rigamonti et al.47 Details on the procedures and the antibodies are provided
in Supplementary data and Supplementary Table S3.
RT-qPCR analyses. Total RNA was extracted from muscles by using TRIzol
reagent (Invitrogen). Total RNA (1 μg) was reverse transcribed with random
hexameric primers and MultiScribe reverse transcriptase (Applied Biosystems,
Warrington, UK). cDNAs were quantified by quantitative real-time PCR on a MX
3000 apparatus (Stratagene, La Jolla, CA, USA) by using specific primers. Primer
sequences are provided in Supplementary data and Supplementary Table S4. PCR
amplification was performed in a volume of 20 μl containing 5 ng cDNA, 300 nM of
each primer, GoTaq qPCR Master Mix (Promega, Madison, WI, USA). Gene
expression changes were normalised to 36B4 or Ppia gene expression by using the
ΔΔCT method. XBP1 splicing assay was performed with TaqMan PerkinElmer
assays (Perkin Elmer, Boston, MA, USA), as described.48
Electron transmission microscopy. Muscle tissue blocks were fixed in
2.5% glutaraldehyde in 0.1 M phosphate buffer (pH 7.4). Post-fixation was
performed in 1% OsO4 in 0.1 M cacodylate buffer (pH 7.4) supplemented with 1.5%
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K4[Fe(CN)6]. Subsequently, samples were dehydrated and embedded in epon.
Ultrathin sections were examined by using a LEO 912AB electron microscope.
Assay of GTPase activity. Forty milligram of quadriceps muscle was
homogenised in RIPA buffer containing 50 mM Tris-HCl, 150 mM NaCl, 1% NP-40,
1% sodium deoxycholate, SDS 0,1% and the protease inhibitor cocktail (pH 7.5).
After centrifugation at 12 000 r.p.m. for 5 min, the supernatant was recovered and
protein concentration was quantified. 300 μg of proteins were incubated in a
reaction buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM MgOAc2, 1 mM dithiothreitol,
the protease inhibitor cocktail, pH 7.5) with 50 μl GTP-agarose beads (Sigma) at
30 °C for 1 h. The beads were centrifuged at 3000 r.p.m. for 5 min and washed three
times in the reaction buffer and the proteins were resolved on SDS-PAGE and
analysed by immunoblotting by using anti-Opa1 antibody.
Quantification of mitochondrial DNA (mtDNA) copy number per
nuclear DNA (nuDNA). Total genomic DNA was isolated by using the
QIAamp DNA Micro kit (Qiagen, Venlo, Netherlands). The amount of mtDNA per
nuclear genome was quantified by qPCR by using specific primers for cytochrome
b, ND2, 28 S and Pecam. Primers sequences are provided in Supplementary Table
S4. Quantification of the relative copy number of mtDNA per nuDNA was analysed
by using the ΔCT method.
Mitochondrial membrane potential analysis. Gastrocnemius myofi-
bres were loaded with 25 nM tetramethyl rhodamine methyl ester (TMRM, Molecular
Probes, Eugene, OR, USA) for 30 min at 37 °C. Sequential images of TMRM
fluorescence were acquired every 60 s with a x40 objective on confocal microscope
(UltraView, Perkin Elmer), with or without the administration of the ATP synthase
inhibitor oligomycin (5 uM) (Sigma-Aldrich) or the protonophore carbonyl cyanide
p-trifluoro-methoxyphenylhydrazone (FCCP, 4 uM) (Sigma-Aldrich).
Preparation of isolated mitochondria. Mitochondria from TA muscle
were obtained as described49 with slight modifications. Details are provided in
Supplemental Experimental Procedures.
Measurement of ATP formation. ATP concentration was determined by
using the luciferin/luciferase method as in6 and details are provided in Supplemental
Experimental Procedures.
Oxygen consumption on permeabilised fibres. Oxygen consumption
on the isolated TA fibres was performed as in.6 Details of the procedure are
described in Supplemental Experimental Procedures.
Polysome analysis and translational control. Polysome isolation on
sucrose gradients (10–50%) and RNA extraction were performed as previously
described50 by using a pool of two frozen quadriceps from P40 control or Drp/MC
mice (n= 3). Same muscle protein amount was layered on the gradients. Synthetic
luciferase reporter mRNA (3 ng) was added in each fraction before extraction and
was used as an internal control. Reverse transcription and qPCR were performed
as above but the measurements were normalised to luciferase abundance.
Statistics. Statistical significance of variations among the different experimental
groups was determined by two-tailed Student's t-test (Prism 5, GraphPad Software).
P -values o0.05 were considered significant.
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